Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2151 USD | -6.48% | +9.74% | +47.94% |
May. 13 | Galera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 7.91M |
---|---|---|---|---|---|
Net income 2022 | -62M | Net income 2023 | -59M | EV / Sales 2022 | - |
Net Debt 2022 | 108M | Net Debt 2023 | 134M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.65
x | P/E ratio 2023 |
-0.11
x | Employees | 7 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 63.85% |
1 day | -6.48% | ||
1 week | +9.74% | ||
1 month | +13.33% | ||
3 months | -7.96% | ||
6 months | +51.59% | ||
Current year | +47.94% |
Managers | Title | Age | Since |
---|---|---|---|
Dennis P. Riley
FOU | Founder | - | 08-12-31 |
J. Sorensen
CEO | Chief Executive Officer | 67 | 12-10-31 |
Robert Beardsley
FOU | Founder | 63 | 08-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Beardsley
FOU | Founder | 63 | 08-12-31 |
Michael Powell
CHM | Chairman | 69 | 16-11-27 |
Kevin Lokay
BRD | Director/Board Member | 67 | 19-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.2151 | -6.48% | 1,176,009 |
24-05-30 | 0.23 | +17.35% | 2,160,143 |
24-05-29 | 0.196 | -3.92% | 579,892 |
24-05-28 | 0.204 | +4.08% | 974,748 |
24-05-24 | 0.196 | +10.11% | 782,746 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+47.94% | 11.7M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- GRTX Stock